top of page
ABOUT US_banner.jpg



Who we are

Cytora LTD, is a Cell Therapy Company that commenced operations in 2018.

Cytora has discovered a novel stem cell population derived from the readily accessible oral mucosa termed human oral mucosa stem cells - hOMSC.

Cytora has developed a revolutionary technology to produce “off the shelf” (allogeneic) therapeutic doses of hOMSC to treat some of the most challenging diseases of this decade including chronic wounds such as incurable diabetic foot ulcers (IDFU) and degenerative diseases such as Parkinson's Disease, Multiple System Atrophy (MSA), and Alzheimer’s Disease.

Our Mission_Vision_banner backg.jpg
Our Mission

Cytora is on a mission to make it standard practice for people to be treated with off-the-shelf Stem Cell medicines for some of the most challenging diseases within this decade.

Our Vision

Our vision is to improve and save the lives of millions of patients worldwide through our unique patented stem cell platform technology, making it accessible and affordable.

bottom of page